• 1
    Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832836.
  • 2
    Linblad J, Farr R. The incidence of positive intradermal reactions and the demonstration of skin sensitizing antibody to extracts of ragweed and dust in humans without history of rhinitis or asthma. J Allergy 1961;32:392.
  • 3
    Roane J, Crawford L, Triplett F, Brasher G. Intradermal tests in nonatopic children. Ann Allergy 1968;26:443.
  • 4
    Barbee RA, Lebowitz MD, Thompson HC, Burrows B. Immediate skin-test reactivity in a general population sample. Ann Intern Med 1976;84:129133.
  • 5
    Backer V, Ulrik CS, Hansen KK, Laursen EM, Dirksen A, Bach-Mortensen N. Atopy and bronchial responsiveness in random population sample of 527 children and adolescents. Ann Allergy 1992;69:116122.
  • 6
    Baldacci S, Modena P, Carrozzi L, Pedreschi M, Vellutini M, Biavati P et al. Skin prick test reactivity to common aeroallergens in relation to total IgE, respiratory symptoms, and smoking in a general population sample of northern Italy. Allergy 1996;51:149156.
  • 7
    Jansen DF, Rijcken B, Schouten JP, Kraan J, Weiss ST, Timens W et al. The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness. Am J Respir Crit Care Med 1999;159:924931.
  • 8
    Kerkhof M, Schouten JP, De Monchy JG. The association of sensitization to inhalant allergens with allergy symptoms: the influence of bronchial hyperresponsiveness and blood eosinophil count. Clin Exp Allergy 2000;30:13871394.
  • 9
    Hagy GW, Settipane GA. Risk factors for developing asthma and allergic rhinitis. A 7-year follow-up study of college students. J Allergy Clin Immunol 1976;58:330336.
  • 10
    Rasmussen F, Siersted HC, Lambrechtsen J, Hansen HS, Hansen NC. Impact of airway lability, atopy, and tobacco smoking on the development of asthma-like symptoms in asymptomatic teenagers. Chest 2000;117:13301335.
  • 11
    Peat JK, Salome CM, Woolcock AJ. Longitudinal changes in atopy during a 4-year period: relation to bronchial hyperresponsiveness and respiratory symptoms in a population sample of Australian schoolchildren. J Allergy Clin Immunol 1990;85(1 Pt 1):6574.
  • 12
    Bodtger U, Poulsen LK, Malling HJ. Asymptomatic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study. J Allergy Clin Immunol 2003;111:149154.
  • 13
    Lau S, Nickel R, Niggemann B, Gruber C, Sommerfeld C, Illi S et al. The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatr Respir Rev 2002; 3:265272.
  • 14
    Sunyer J, Jarvis D, Pekkanen J, Chinn S, Janson C, Leynaert B et al. Geographic variations in the effect of atopy on asthma in the European Community Respiratory Health Study. J Allergy Clin Immunol 2004;114:10331039.
  • 15
    Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H. The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896904.
  • 16
    Pauli G. Evolution in the understanding of cross-reactivities of respiratory allergens: the role of recombinant allergens. Int Arch Allergy Immunol 2000;123:183195.
  • 17
    Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, Twardosz A et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. Faseb J 2002;16:414416.
  • 18
    Pepys J. Types of allergic reaction. Clin Allergy 1973;3(Suppl.):491509.
  • 19
    Pepys J. ‘‘Atopy’’: a study in definition. Allergy 1994;49:397399.
  • 20
    Valenta R, Duchene M, Ebner C, Valent P, Sillaber C, Deviller P et al. Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 1992;175:377385.
  • 21
    Bousquet J, Coulomb Y, Arrendal H, Robinet-Levy M, Michel FB. Total serum IgE concentrations in adolescents and adults using the phadebas IgE PRIST technique. Allergy 1982;37:397406.
  • 22
    Bousquet J, Knani J, Hejjaoui A, Ferrando R, Cour P, Dhivert H et al. Heterogeneity of atopy. I. Clinical and immunologic characteristics of patients allergic to cypress pollen. Allergy 1993;48:183188.
  • 23
    Rudin A, Macaubas C, Wee C, Holt BJ, Slya PD, Holt PG. ‘‘Bystander’’ amplification of PBMC cytokine responses to seasonal allergen in polysensitized atopic children. Allergy 2001;56:10421048.
  • 24
    Pene J, Rivier A, Lagier B, Becker WM, Michel FB, Bousquet J. Differences in IL-4 release by PBMC are related with heterogeneity of atopy. Immunology 1994;81:5864.
  • 25
    Lagier B, Pons N, Rivier A, Chanal I, Chanez P, Bousquet J et al. Seasonal variations of interleukin-4 and interferon-gamma release by peripheral blood mononuclear cells from atopic subjects stimulated by polyclonal activators. J Allergy Clin Immunol 1995;96(6 Pt 1):932940.
  • 26
    Bousquet J, Hejjaoui A, Becker WM, Cour P, Chanal I, Lebel B et al. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics. J Allergy Clin Immunol 1991;87:737746.
  • 27
    Marsh DG, Chase GA, Freidhoff LR, Meyers DA, Bias WB. Association of HLA antigens and total serum immunoglobulin E level with allergic response and failure to respond to ragweed allergen Ra3. Proc Natl Acad Sci U S A 1979;76:29032907.
  • 28
    Fischer GF, Pickl WF, Fae I, Ebner C, Ferreira F, Breiteneder H et al. Association between IgE response against Bet v I, the major allergen of birch pollen, and HLA-DRB alleles. Hum Immunol 1992;33:259265.
  • 29
    Tautz C, Rihs HP, Thiele A, Zwollo P, Freidhoff LR, Marsh DG et al. Association of class II sequences encoding DR1 and DQ5 specificities with hypersensitivity to chironomid allergen Chi t I. J Allergy Clin Immunol 1994;93:918925.
  • 30
    Soriano JB, Ercilla G, Sunyer J, Real FX, Lazaro C, Rodrigo MJ et al. HLA class II genes in soybean epidemic asthma patients. Am J Respir Crit Care Med 1997;156:13941398.
  • 31
    D'Amato M, Scotto d'Abusco A, Maggi E, Menna T, Sacerdoti G, Maurizio SM et al. Association of responsiveness to the major pollen allergen of Parietaria officinalis with HLA-DRB1* alleles: a multicenter study. Hum Immunol 1996;46:100106.
  • 32
    Doherty DG, Penzotti JE, Koelle DM, Kwok WW, Lybrand TP, Masewicz S et al. Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. J Immunol 1998;161:35273535.
  • 33
    Joshi SK, Suresh PR, Chauhan VS. Flexibility in MHC and TCR recognition: degenerate specificity at the T cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology. J Immunol 2001;166:66936703.
  • 34
    D'Amato M, Picardi A, Menna T, Di Somma C, Ariano R, Di Pietro A et al. HLA-DRB1* and allergy to Parietaria: linkage and association analyses. Hum Immunol 1999;60:12501258.
  • 35
    Geller-Bernstein C, Lahoz C, Cardaba B, Hassoun G, Iancovici-Kidon M, Kenett R et al. Is it ‘bad hygiene’ to inhale pollen in early life? Allergy 2002;57(Suppl. 71):3740.
  • 36
    Silvestri M, Rossi GA, Cozzani S, Pulvirenti G, Fasce L. Age-dependent tendency to become sensitized to other classes of aeroallergens in atopic asthmatic children. Ann Allergy Asthma Immunol 1999;83:335340.
  • 37
    Asero R. Birch and ragweed pollinosis north of Milan: a model to investigate the effects of exposure to ‘‘new’’ airborne allergens. Allergy 2002;57:10631066.
  • 38
    Ramirez DA. The natural history of mountain cedar pollinosis. J Allergy Clin Immunol 1984;73(1 Pt 1):8893.
  • 39
    Reid MJ, Schwietz LA, Whisman BA, Moss RB. Mountain cedar pollinosis: can it occur in non-atopics? N Engl Reg Allergy Proc 1988;9:225232.
  • 40
    Pastorello EA, Incorvaia C, Ortolani C, Bonini S, Canonica GW, Romagnani S et al. Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol 1995;96(5 Pt 1):580587.
  • 41
    Pastorello EA, Farioli L, Pravettoni V, Ispano M, Conti A, Ansaloni R et al. Sensitization to the major allergen of Brazil nut is correlated with the clinical expression of allergy. J Allergy Clin Immunol 1998;102(6 Pt 1):10211027.
  • 42
    Sampson HA. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol 2001;107:891896.
  • 43
    Boyano Martinez T, Garcia-Ara C, Diaz-Pena JM, Munoz FM, Garcia Sanchez G, Esteban MM. Validity of specific IgE antibodies in children with egg allergy. Clin Exp Allergy 2001;31:14641469.
  • 44
    Boyano-Martinez T, Garcia-Ara C, Diaz-Pena JM, Martin-Esteban M. Prediction of tolerance on the basis of quantification of egg white-specific IgE antibodies in children with egg allergy. J Allergy Clin Immunol 2002;110:304309.
  • 45
    Rance F, Abbal M, Lauwers-Cances V. Improved screening for peanut allergy by the combined use of skin prick tests and specific IgE assays. J Allergy Clin Immunol 2002;109:10271033.
  • 46
    Niederberger V, Stubner P, Spitzauer S, Kraft D, Valenta R, Ehrenberger K et al. Skin test results but not serology reflect immediate type respiratory sensitivity: a study performed with recombinant allergen molecules. J Invest Dermatol 2001;117:848851.
  • 47
    Saxon A, Diaz-Sanchez D, Zhang K. Regulation of the expression of distinct human secreted IgE proteins produced by alternative RNA splicing. Biochem Soc Trans 1997;25:383387.
  • 48
    Ahlstedt S, Eriksson NE. Immunotherapy in atopic allergy – antibody titres and avidities during hyposensitization with birch and timothy pollen allergens. Int Arch Allergy Appl Immunol 1977;55:400411.
  • 49
    Mitchell AJ, Moss ND, Collins AM. The biological activity of serum IgE changes over the course of a primary response. Scand J Immunol 2002;55:3343.
  • 50
    Van-Ree R. Factors modulating allergen-induced histamine release. In: BousquetJ, YsselH, eds. Immunotherapy in asthma. New York: Marcel Dekker, 1999:848855.
  • 51
    Van Ree R, Aalberse RC. Specific IgE without clinical allergy. J Allergy Clin Immunol 1999;103:10001001.
  • 52
    Van Ree R. Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 2002;129:189197.
  • 53
    Purohit A, Laffer S, Metz-Favre C, Verot A, Kricek F, Valenta R et al. Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to FcɛRI. Clin Exp Allergy 2005;35:186192.
  • 54
    Vercelli D, De Monte L, Monticelli S, Di Bartolo C, Agresti A. To E or not to E? Can an IL-4-induced B cell choose between IgE and IgG4? Int Arch Allergy Immunol 1998;116:14.
  • 55
    Wahn U, Lau S, Bergmann R, Kulig M, Forster J, Bergmann K et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol 1997;99(6 Pt 1):763769.
  • 56
    Huss K, Adkinson NF Jr, Eggleston PA, Dawson C, Van Natta ML, Hamilton RG. House dust mite and cockroach exposure are strong risk factors for positive allergy skin test responses in the Childhood Asthma Management Program. J Allergy Clin Immunol 2001;107:4854.
  • 57
    Ownby DR, Johnson CC, Peterson EL. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age. JAMA 2002;288:963972.
  • 58
    Celedon JC, Litonjua AA, Ryan L, Platts-Mills T, Weiss ST, Gold DR. Exposure to cat allergen, maternal history of asthma, and wheezing in first 5 years of life. Lancet 2002;360:781782.
  • 59
    Melen E, Wickman M, Nordvall SL, Van Hage-Hamsten M, Lindfors A. Influence of early and current environmental exposure factors on sensitization and outcome of asthma in pre-school children. Allergy 2001;56:646652.
  • 60
    Almqvist C, Egmar AC, Van Hage-Hamsten M, Berglind N, Pershagen G, Nordvall SL et al. Heredity, pet ownership, and confounding control in a population-based birth cohort. J Allergy Clin Immunol 2003;111:800806.
  • 61
    Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001;357:752756.
  • 62
    Woodfolk JA, Platts-Mills TA. The immune response to intrinsic and extrinsic allergens: determinants of allergic disease. Int Arch Allergy Immunol 2002;129:277285.
  • 63
    Flicker S, Valenta R. Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol 2003;132:1324.
  • 64
    Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth MT, Valent P et al. Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A 2004;101(Suppl. 2):1467714682.
  • 65
    Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K et al. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003;33:12051214.
  • 66
    Aghayan-Ugurluoglu R, Ball T, Vrtala S, Schweiger C, Kraft D, Valenta R. Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol 2000;105:803813.
  • 67
    Godfrey RC. Asthma and IgE levels in rural and urban communities of The Gambia. Clin Allergy 1975;5:201207.
  • 68
    Merrett TG, Merrett J, Cookson JB. Allergy and parasites: the measurement of total and specific IgE levels in urban and rural communities in Rhodesia. Clin Allergy 1976;6:131134.
  • 69
    Lynch NR, Lopez RI, Di Prisco-Fuenmayor MC, Hagel I, Medouze L, Viana G et al. Allergic reactivity and socio-economic level in a tropical environment. Clin Allergy 1987; 17:199207.
  • 70
    Lynch NR, Hagel I, Perez M, Di Prisco MC, Lopez R, Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J Allergy Clin Immunol 1993;92:404411.
  • 71
    Hagel I, Lynch NR, Di Prisco MC, Rojas E, Perez M, Alvarez N. Ascaris reinfection of slum children: relation with the IgE response. Clin Exp Immunol 1993;94:8083.
  • 72
    Lynch NR, Hagel IA, Palenque ME, Di Prisco MC, Escudero JE, Corao LA et al. Relationship between helminthic infection and IgE response in atopic and nonatopic children in a tropical environment. J Allergy Clin Immunol 1998;101(2 Pt 1):217221.
  • 73
    Van Den Biggelaar AH, Lopuhaa C, Van Ree R, Van Der Zee JS, Jans J, Hoek A et al. The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren. Int Arch Allergy Immunol 2001;126:231238.
  • 74
    Scrivener S, Yemaneberhan H, Zebenigus M, Tilahun D, Girma S, Ali S et al. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001;358:14931499.
  • 75
    MacGlashan D Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J et al. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:14381445.
  • 76
    Yssel H, Johnson KE, Schneider PV, Wideman J, Terr A, Kastelein R et al. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J Immunol 1992;148:738745.
  • 77
    Ebner C, Schenk S, Najafian N, Sremann U, Steiner R, Fisher GW et al. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995;154:19321940.
  • 78
    Cardaba B, Del Pozo V, Jurado A, Gallardo S, Cortegano I, Arrieta I et al. Olive pollen allergy: searching for immunodominant T-cell epitopes on the Ole e 1 molecule. Clin Exp Allergy 1998;28:413422.
  • 79
    Roncarolo MG, Gregori S, Levings M. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells. Novartis Found Symp 2003;252:115127. discussion 127–131, 203–210.
  • 80
    Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22:531562.
  • 81
    Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:15671575.
  • 82
    Akbari O, Stock P, DeKruyff RH, Umetsu DT. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003;15:627633.
  • 83
    Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363:608615.
  • 84
    Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 2004;34:13641372.
  • 85
    Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 2004;199:16791688.
  • 86
    Seneviratne SL, Jones L, King AS, Black A, Powell S, McMichael AJ et al. Allergen-specific CD8(+) T cells and atopic disease. J Clin Invest 2002;110:12831291.
  • 87
    Pierkes M, Bellinghausen I, Hultsch T, Metz G, Knop J, Saloga J. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells. J Allergy Clin Immunol 1999;103(2 Pt 1):326332.
  • 88
    Hill MR, James AL, Faux JA, Ryan G, Hopkin JM, Le Souef P et al. Fc epsilon RI-beta polymorphism and risk of atopy in a general population sample. BMJ 1995;311:776779.
  • 89
    Van Herwerden L, Harrap SB, Wong ZY, Abramson MJ, Kutin JJ, Forbes AB et al. Linkage of high-affinity IgE receptor gene with bronchial hyperreactivity, even in absence of atopy. Lancet 1995;346:12621265.
  • 90
    Ishizawa M, Shibasaki M, Yokouchi Y, Noguchi E, Arinami T, Yamakawa-Kobayashi K et al. No association between atopic asthma and a coding variant of Fc epsilon R1 beta in a Japanese population. J Hum Genet 1999;44:308311.
  • 91
    Rohrbach M, Kraemer R, Liechti-Gallati S. Screening of the Fc epsilon RI-beta-gene in a Swiss population of asthmatic children: no association with E237G and identification of new sequence variations. Dis Markers 1998;14:177186.
  • 92
    Haider MZ, Hijazi Z. Prevalence of high affinity IgE receptor [Fc epsilon RI beta] gene polymorphisms in Kuwaiti Arabs with asthma. Clin Genet 1998;54:166167.
  • 93
    Cox HE, Moffatt MF, Faux JA, Walley AJ, Coleman R, Trembath RC et al. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 1998;138:182187.
  • 94
    Cardaba B, Cortegano I, Florido F, Arrieta I, Aceituno E, Del Pozo V et al. Genetic restrictions in olive pollen allergy. J Allergy Clin Immunol 2000;105(2 Pt 1):292298.
  • 95
    Van Hage-Hamsten M, Johansson E, Kronqvist M, Loughry A, Cookson WO, Moffatt MF. Associations of Fc epsilon R1-beta polymorphisms with immunoglobulin E antibody responses to common inhalant allergens in a rural population. Clin Exp Allergy 2002;32:838842.
  • 96
    Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, McCloskey N, Coker HA et al. The biology of IgE and the basis of allergic disease. Annu Rev Immunol 2002;18:18.
  • 97
    Bernstein IL, Vijay HM, Perelmutter L. Non-responder basophils in highly ragweed-sensitive subjects. Int Arch Allergy Appl Immunol 1977;55:215216.
  • 98
    Marone G, Poto S, Giugliano R, Celestino D, Bonini S. Control mechanisms of human basophil releasability. J Allergy Clin Immunol 1986; 78(5 Pt 2):974980.
  • 99
    Casolaro V, Spadaro G, Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990;142:11081111.
  • 100
    MacGlashan D Jr. Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. J Allergy Clin Immunol 1993;91:605615.
  • 101
    Paris-Kohler A, Demoly P, Persi L, Lebel B, Bousquet J, Arnoux B. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000;105:339345.
  • 102
    MacGlashan D Jr, McKenzie-White J, Chichester K, Bochner BS, Davis FM, Schroeder JT et al. In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody. Blood 1998;91:16331643.
  • 103
    Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773786.
  • 104
    Benhamou M, Bonnerot C, Fridman WH, Daeron M. Molecular heterogeneity of murine mast cell Fc gamma receptors. J Immunol 1990;144:30713077.
  • 105
    Daeron M, Malbec O, Latour S, Arock M, Fridman WH. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577585.
  • 106
    Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR- dependent cell activation. Immunity 1995;3:635646.
  • 107
    Daeron M. Fc receptor biology. Annu Rev Immunol 1997;15:203234.
  • 108
    Kepley CL, Taghavi S, Mackay GA, Zhu D, Morel PA, Zhang K et al. Co-aggregation of Fcgamma RII With Fcepsilon RI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes. J Biol Chem 2004.
  • 109
    Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996;379:346349.
  • 110
    Ujike A, Ishikawa Y, Ono M, Yuasa T, Yoshino T, Fukumoto M et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med 1999;189:15731579.
  • 111
    Ali K, Bilancio A, Thomas M, Pearce W, Gilfillan AM, Tkaczyk C et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004;431:10071011.
  • 112
    Tkaczyk C, Okayama Y, Metcalfe DD, Gilfillan AM. Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release. Int Arch Allergy Immunol 2004;133:305315.
  • 113
    Maurer D, Fiebiger E, Reininger B, Wolff-Winiski B, Jouvin MH, Kilgus O et al. Expression of functional high affinity immunoglobulin E receptors (Fc epsilon RI) on monocytes of atopic individuals. J Exp Med 1994;179:745750.
  • 114
    Novak N, Allam JP, Betten H, Haberstok J, Bieber T. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy 2004;59:514.
  • 115
    Foster B, Metcalfe DD, Prussin C. Human dendritic cell 1 and dendritic cell 2 subsets express FcepsilonRI: correlation with serum IgE and allergic asthma. J Allergy Clin Immunol 2003;112:11321138.
  • 116
    Kepley CL, Zhang K, Zhu D, Saxon A. FcepsilonRI-FcgammaRII coaggregation inhibits IL-16 production from human Langerhans-like dendritic cells. Clin Immunol 2003;108:8994.
  • 117
    Von-Bubnoff D, Sheler M, Hinz T, Matz H, Koch S, Bieber T. Comparative immunophenotyping of monocytes from symptomatic and asymptomatic atopic individuals. Allergy 2004;59:933939.
  • 118
    Balaban N, Rasooly A. Staphylococcal enterotoxins. Int J Food Microbiol 2000;61:110.
  • 119
    Hofer MF, Harbeck RJ, Schlievert PM, Leung DY. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999;112:171176.
  • 120
    Shiomori T, Yoshida S, Miyamoto H, Makishima K. Relationship of nasal carriage of Staphylococcus aureus to pathogenesis of perennial allergic rhinitis. J Allergy Clin Immunol 2000;105:449454.
  • 121
    Bachert C, Gevaert P, Holtappels G, Johansson SG, Van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607614.
  • 122
    Bachert C, Gevaert P, Howarth P, Holtappels G, Van Cauwenberge P, Johansson SG. IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. J Allergy Clin Immunol 2003;111:11311132.
  • 123
    Rohde G, Gevaert P, Holtappels G, Borg I, Wiethege A, Arinir U et al. Increased IgE-antibodies to Staphylococcus aureus enterotoxins in patients with COPD. Respir Med 2004;98:858864.
  • 124
    MacIntyre UE, De Villiers FP, Owange-Iraka JW. Increase in childhood asthma admissions in an urbanising population. S Afr Med J 2001;91:667672.
  • 125
    Addo-Yobo EO, Custovic A, Taggart SC, Asafo-Agyei AP, Woodcock A. Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren. Thorax 1997;52:161165.
  • 126
    Ng'ang'a LW, Odhiambo JA, Omwega MJ, Gicheha CM, Becklake MR, Menzies R et al. Exercise-induced bronchospasm: a pilot survey in Nairobi school children. East Afr Med J 1997;74:694698.
  • 127
    Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J. Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997;350:8590.
  • 128
    Odhiambo JA, Ng'ang'a LW, Mungai MW, Gicheha CM, Nyamwaya JK, Karimi F et al. Urban-rural differences in questionnaire-derived markers of asthma in Kenyan school children. Eur Respir J 1998;12:11051112.
  • 129
    Nyan OA, Walraven GE, Banya WA, Milligan P, Van Der Sande M, Ceesay SM et al. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin Exp Allergy 2001;31:16721678.
  • 130
    Walraven GE, Nyan OA, Van Der Sande MA, Banya WA, Ceesay SM, Milligan PJ et al. Asthma, smoking and chronic cough in rural and urban adult communities in The Gambia. Clin Exp Allergy 2001;31:16791685.
  • 131
    Sunyer J, Torregrosa J, Anto J, Menendez C, Acosta C, Schellenberg D et al. The association between atopy and asthma in a semirural area of Tanzania (East Africa). Allergy 2000;55:762767.
  • 132
    Westritschnig K, Sibanda E, Thomas W, Auer H, Aspock H, Pittner G et al. Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy 2003;33:2227.
  • 133
    Scrivener S, Britton J. Immunoglobulin E and allergic disease in Africa. Clin Exp Allergy 2000;30:304307.
  • 134
    Borkow G, Leng Q, Weisman Z, Stein M, Galai N, Kalinkovich A et al. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest 2000;106:10531060.
  • 135
    Selassie FG, Stevens RH, Cullinan P, Pritchard D, Jones M, Harris J et al. Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar, Ethiopia. Clin Exp Allergy 2000;30:356358.
  • 136
    Ottesen EA, Skvaril F, Tripathy SP, Poindexter RW, Hussain R. Prominence of IgG4 in the IgG antibody response to human filariasis. J Immunol 1985;134:27072712.
  • 137
    Kurniawan A, Yazdanbakhsh M, Van Ree R, Aalberse R, Selkirk ME, Partono F et al. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. J Immunol 1993;150:39413950.
  • 138
    Hussain R, Poindexter RW, Ottesen EA. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibody to the IgG4 subclass. J Immunol 1992;148:27312737.
  • 139
    Atmadja AK, Atkinson R, Sartono E, Partono F, Yazdanbakhsh M, Maizels RM. Differential decline in filaria-specific IgG1, IgG4, and IgE antibodies in Brugia malayi-infected patients after diethylcarbamazine chemotherapy. J Infect Dis 1995;172:15671572.
  • 140
    Yazdanbakhsh M, Van Den Biggelaar A, Maizels RM. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol 2001;22:372377.
  • 141
    Van Den Biggelaar AH, Van Ree R, Rodrigues LC, Lell B, Deelder AM, Kremsner PG et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000;356:17231727.
  • 142
    Holt PG. Parasites, atopy, and the hygiene hypothesis: resolution of a paradox? Lancet 2000;356:16991701.
  • 143
    Yazdanbakhsh M, Kremsner PG, Van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002;296:490494.
  • 144
    Van Den Biggelaar AH, Rodrigues LC, Van Ree R, Van Der Zee JS, Hoeksma-Kruize YC, Souverijn JH et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004;189:892900.
  • 145
    Satti MZ, Cahen P, Skov PS, Joseph S, Jones FM, Fitzsimmons C et al. Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel. BMC Immunol 2004;5:6.
  • 146
    Vuitton DA. The ambiguous role of immunity in echinococcosis: protection of the host or of the parasite? Acta Trop 2003;85:119132.
  • 147
    Vuitton DA. Echinococcosis and allergy. Clin Rev Allergy Immunol 2004;26:93104.
  • 148
    Boyano T, Moldenhauer F, Mira J, Joral A, Saiz F. Systemic anaphylaxis due to hepatic hydatid disease. J Investig Allergol Clin Immunol 1994;4:158159.
  • 149
    Sola JL, Vaquerizo A, Madariaga MJ, Opla JM, Bondia A. Intraoperative anaphylaxis caused by a hydatid cyst. Acta Anaesthesiol Scand 1995;39:273274.
  • 150
    Bryceson AD, Warrell DA, Pope HM. Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine. Br Med J 1977;1:742744.